睡眠輔助市場：依產品類型、睡眠障礙、地區

Sleep Aids Market, By Product Type, By Sleep Disorder, By Geography

出版日期: 2024年04月30日 | 出版商:

Coherent Market Insights | 英文 187 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

根據預測，2024年全球睡眠輔助市場規模將達到776.8億美元，2024年至2031年年複合成長率(CAGR)為7.6%，2031年將達1,295.8億美元。

報告範圍		報告詳情
基準年	2023年	2024年市場規模	776.8億美元
實際資料	2019年至2023年	預測期	從2024年到2031年
預測 2024-2031 年年複合成長率：	7.60%	2031年價值預測	1295.8億美元

圖：2024 年睡眠輔助產品市場佔有率（%），依地區分類

由於睡眠障礙的盛行率不斷增加，全球睡眠輔助市場在過去幾年中穩步成長。壓力水平上升、生活方式的改變和人口老化已成為失眠和其他睡眠障礙的主要因素。此外，人們越來越意識到睡眠不足對健康和生產力的負面影響，並且越來越多的人正在尋求治療。市面上有各種安眠藥和睡眠設備可以幫助人們獲得充分的休息。隨著人們健康意識的增強，草藥和補充品等更多天然產品也越來越受歡迎，以促進睡眠。由於持續的研究和開發帶來的創新以及新興國家不斷成長的需求，預計睡眠輔助市場在未來幾年將進一步顯著成長。

市場動態：

全球睡眠輔助市場主要是由於飲食變化、忙碌的生活方式和壓力水平增加導致的睡眠障礙盛行率上升所推動的。睡眠不足與許多健康問題有關，包括肥胖、心臟病和憂鬱症，這推動了睡眠輔助劑的採用。此外，容易出現睡眠障礙的老年人數量不斷增加，也成為產業企業需要應對的龐大市場。然而，與處方安眠藥相關的副作用和風險已成為主要問題。許多國家對替代療法的偏好也在一定程度上阻礙了市場收益的成長。與此同時，睡眠技術（包括穿戴式裝置和行動應用程式）的創新步伐正在提供新的機會。新興國家對失眠影響的認知不斷提高以及醫療基礎設施的改善將進一步支持未來的產業擴張。

本研究的主要特點

該報告對全球睡眠輔助市場進行了詳細分析，並提供了以 2023 年為基準年的預測期（2024-2031 年）的市場規模（十億美元）和年複合成長率（CAGR%）。
它還強調了各個細分市場的潛在收益成長機會，並說明了該市場有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的主要考察。
它根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，介紹了全球睡眠輔助市場的主要企業。
主要企業包括 Pfizer、GSK plc、Sommetrics, Inc.、Cadwell Industries, Inc.、SleepMed, Inc.、Natus Medical Incorporated、Therapix Biosciences Ltd.、Compumedics Limited、 Eisai、Tris Pharma, Inc.、Novartis AG、Idorsia Pharmaceuticals Ltd.、ResMed 和阿斯特捷利康。
該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球睡眠輔助市場迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過分析全球睡眠輔助市場時所使用的各種策略矩陣來促進他們的決策。

Report Coverage	Report Details
Base Year:	2023	Market Size in 2024:	US$ 77.68 Bn
Historical Data for:	2019 To 2023	Forecast Period:	2024 To 2031
Forecast Period 2024 to 2031 CAGR:	7.60%	2031 Value Projection:	US$ 129.58 Bn

The global sleep aids market has been witnessing steady growth in the last few years owing to the increasing prevalence of sleep disorders. Rising stress levels, changing lifestyles, and growing aging population have emerged as major factors fueling insomnia and other sleep disorders. Moreover, growing awareness about the ill-effects of sleep deprivation on health and productivity are prompting a greater number of people to seek treatment. Various sleep medications and devices have flooded the market to help people get adequate rest. With growing health consciousness, more natural products like herbs and supplements are also gaining popularity for sleep promotion. The sleep aids market is expected to further grow at a notable rate in the coming years on the back of ongoing research and development leading to innovations as well as increasing demand from emerging countries.

Market Dynamics:

The global sleep aids market is driven by the rising prevalence of sleep disorders mainly due to changing dietary patterns, busy lifestyles, and increasing stress levels. Sleep deprivation is linked to numerous health issues like obesity, heart diseases, and depression which has boosted the adoption of sleep aids. The growing geriatric population which is more prone to sleep disorders also presents a large addressable market for industry players. However, side effects and risks associated with prescription sleep drugs pose a major challenge. Also, preference for alternative therapies in many countries hamper the market revenue growth to some extent. On the other hand, pace of innovation in sleep technology involving wearable devices and mobile apps offer new opportunities. Growing awareness about the consequences of insomnia and improving healthcare infrastructure in emerging nations will further support industry expansion going forward.

Key Features of the Study:

This report provides an in-depth analysis of the global sleep aids market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global sleep aids market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this Pfizer Inc., GSK plc, Sommetrics, Inc., Cadwell Industries, Inc., SleepMed, Inc., Natus Medical Incorporated, Therapix Biosciences Ltd, Compumedics Limited, Eisai Co., Ltd., Tris Pharma, Inc., Novartis AG, Idorsia Pharmaceuticals Ltd., ResMed, AstraZeneca.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global sleep aids market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global sleep aids market.

Detailed Segmentation-

By Product Type:
- Medications
- Sleep Apnea Devices
- Mattresses and Pillows
- Others
By Sleep Disorder:
- Insomnia
- Sleep Apnea
- Restless Legs Syndrome
- Night Terrors
- Others
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Pfizer Inc.
- GSK plc
- Sommetrics, Inc.
- Cadwell Industries, Inc.
- SleepMed, Inc.
- Natus Medical Incorporated
- Therapix Biosciences Ltd
- Compumedics Limited
- Eisai Co., Ltd.
- Tris Pharma, Inc.
- Novartis AG
- Idorsia Pharmaceuticals Ltd.
- ResMed
- AstraZeneca

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Sleep Disorder
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Manufacturer Revenue
Acquisitions and Partnerships Scenario
Product Launches/Approvals
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Sleep Aids Market- Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Sleep Aids Market, By Product Type, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Medications
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Sleep Apnea Devices
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Mattresses and Pillows
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Sleep Aids Market, By Sleep Disorder 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Insomnia
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Sleep Apnea
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Restless Legs Syndrome
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Night Terrors
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Sleep Aids Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2031
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sleep Disorder, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.S.
  - Canada
  - Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sleep Disorder, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
  - Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sleep Disorder, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
  - Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sleep Disorder, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
  - Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sleep Disorder, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
  - Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Sleep Disorder, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Company Profiles
- Pfizer Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- GSK plc
- Sommetrics, Inc.
- Cadwell Industries, Inc.
- SleepMed, Inc.
- Natus Medical Incorporated
- Therapix Biosciences Ltd
- Compumedics Limited
- Eisai Co., Ltd.
- Tris Pharma, Inc.
- Novartis AG
- Idorsia Pharmaceuticals Ltd.
- ResMed
- AstraZeneca